Target Name: OR1N1
NCBI ID: G138883
Review Report on OR1N1 Target / Biomarker Content of Review Report on OR1N1 Target / Biomarker
OR1N1
Other Name(s): Olfactory receptor, family 1, subfamily N, member 1 | OR1N3 | Olfactory receptor 1N1 | olfactory receptor, family 1, subfamily N, member 3 | OR1N1_HUMAN | olfactory receptor OR9-22 | OTTHUMP00000022057 | olfactory receptor family 1 subfamily N member 1 | Olfactory receptor 1-26 | Olfactory receptor OR9-22 | Olfactory receptor, family 1, subfamily N, member 3 | OR9-22 | olfactory receptor 1N3 | OR1-26 | olfactory receptor 1-26 | Olfactory receptor 1N3 | Olfactory receptor family 1 subfamily N member 1

Understanding OR1N1: A GPCR Gene Involved in Smell and Disease

Olfactory receptor, family 1, subfamily N, member 1 (OR1N1) is a protein that plays a crucial role in the sense of smell. It is a G protein-coupled receptor (GPCR) that is expressed in the taste buds and the vomiting system of the human body. OR1N1 is one of the many GPCR genes that have been identified as potential drug targets in recent years due to its involvement in various physiological processes.

The OR1N1 gene is located on chromosome 11 and encodes a protein that consists of an extracellular domain, a transmembrane region, and an intracellular domain. The transmembrane region of OR1N1 contains the extracellular portion of the protein that interacts with various signaling molecules, including G protein-coupled receptors. The intracellular domain of OR1N1 contains the intracellular portion of the protein that interacts with the intracellular signaling pathway.

OR1N1 is involved in the sense of smell because it is a critical receptor for the neurotransmitter olfactory nerve signal, which is responsible for transmitting the sense of smell to the brain. When the olfactory nerve signal is triggered, it causes a signaling cascade that activates various GPCR signaling pathways, including the TGF-β pathway and the MAPK/ERK signaling pathway. These signaling pathways are involved in the regulation of various cellular processes, including cell growth, differentiation, and survival.

OR1N1 is a strong candidate for drug targeting because of its involvement in various physiological processes that are affected by various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. For example, OR1N1 has been shown to be involved in the regulation of neurotransmitter release from the olfactory nerve in individuals with Alzheimer's disease. Additionally, OR1N1 has been shown to be involved in the regulation of pain perception, which is a key aspect of neurodegenerative diseases such as Parkinson's disease.

In addition to its involvement in neurotransmission, OR1N1 is also a potential biomarker for various diseases. For example, OR1N1 has been shown to be elevated in individuals with depression and anxiety, which are associated with various psychiatric disorders. Additionally, OR1N1 has been shown to be elevated in individuals with cancer, which is associated with various diseases.

In conclusion, OR1N1 is a GPCR gene that is involved in the sense of smell and the regulation of various physiological processes in the human body. Its involvement in neurotransmission and its potential as a biomarker make it a promising target for drug development. Further research is needed to fully understand the role of OR1N1 in various diseases and to develop effective therapies that target this protein.

Protein Name: Olfactory Receptor Family 1 Subfamily N Member 1

Functions: Odorant receptor

The "OR1N1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR1N1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11